The ADAMs family of proteases as targets for the treatment of cancer

Por Mullooly, Maeve, McGowan, Patricia M., Crown, John, Duffy, Michael J.
Publicado no Cancer Biol Ther (2016)

uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies

Por Duffy, Michael J, McGowan, Patricia M, Harbeck, Nadia, Thomssen, Christoph, Schmitt, Manfred
Publicado no Breast Cancer Res (2014)

The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

Por Duffy, Michael J, Mullooly, Maeve, O'Donovan, Norma, Sukor, Sumainizah, Crown, John, Pierce, Aisling, McGowan, Patricia M
Publicado em 2011

ADAM10: a new player in breast cancer progression?

Por Mullooly, Maeve, McGowan, Patricia M, Kennedy, Susan A, Madden, Stephen F, Crown, John, O' Donovan, Norma, Duffy, Michael J
Publicado no Br J Cancer (2015)

Notch1 inhibition alters the CD44(hi)/CD24(lo) population and reduces the formation of brain metastases from breast cancer

Por McGowan, Patricia M., Simedrea, Carmen, Ribot, Emeline J., Foster, Paula J., Palmieri, Diane, Steeg, Patricia S., Allan, Alison L., Chambers, Ann F.
Publicado em 2011

Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines

Por Pierce, Aisling, McGowan, Patricia M., Cotter, Maura, Mullooly, Maeve, O’Donovan, Norma, Rani, Sweta, O’Driscoll, Lorraine, Crown, John, Duffy, Michael J.
Publicado em 2013

ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis

Por Romagnoli, Mathilde, Mineva, Nora D, Polmear, Michael, Conrad, Catharina, Srinivasan, Srimathi, Loussouarn, Delphine, Barillé-Nion, Sophie, Georgakoudi, Irene, Dagg, Áine, McDermott, Enda W, Duffy, Michael J, McGowan, Patricia M, Schlomann, Uwe, Parsons, Maddy, Bartsch, Jörg W, Sonenshein, Gail E
Publicado em 2014